Glycosides from Proteaceae
J ournal of Natural Products, 1999, Vol. 62, No. 11 1529
Compound 2a was refluxed with 10% HCl-MeOH, under
N2, for 2 h. The solution was evaporated under N2, taken up
with H2O and extracted with CH2Cl2. After purification on Si
gel (n-hexane-EtOAc, 4:1), 11 mg of 3,4 dimethoxyphenol (2b)
were obtained: 1H NMR (200 MHz, CDCl3) δ 6.74 (1H, d, J )
8.7 Hz, H-5), 6.48 (1H, d, J ) 2.7 Hz, H-2), 6.35 (1H, dd, J )
8.7, 2.7 Hz, H-6), 5.03 (1H, s, -OH), 3.83 (6H, s, -OCH3).
Com p ou n d 3: white powder, mp 189-190 °C (EtOH-
CHCl3 ) [R]20D -48° (c 1, MeOH), Rf 0.41 (CHCl3-MeOH-H2O
5:5:3, organic phase); 1H NMR (DMSO-d6, 300 MHz) δ 8.94
and 8.40 (2H, s, phenolic OH), 8.00 (2H, dd, J ) 7.2, 1.5 Hz,
H-2′′,-6′′), 7.70 (1H, t, J ) 7.2 Hz, H-4′′), 7.57 (2H, t, J ) 7.2
Hz, H-3′′,-5′′), 6.86 (1H, d, J ) 8.7 Hz, H-6), 6.22 (1H, d, J )
2.7 Hz, H-3), 5.90 (1H, dd, J ) 8.7, 2.7 Hz, H-5), 5.60 (1H, s,
OH), 4.63 (1H, dd, J ) 11.9, 1.5 Hz, H-6′A), 4.56 (1H, d, J )
7.9 Hz, H-1′), 4.30 (1H, dd, J ) 11.9,7.7 Hz, H-6′B), 3.68 (1H,
dt, J ) 7.7, 1.5 Hz, H-5′), 3.29 (3H, m, H-2′,-3′,-4′); 13C NMR
(DMSO-d6) δ 165.7 (s, C-7′′), 153.4 (s, C-4), 147.7 (s, C-2), 138.3
(s, C-1), 133.6 (d, C-4′′), 129.7 (s, C-1′′), 2 × 129.3 (d,
C-2′′,-6′′), 2 × 128.9 (d, C-3′′,-5′′), 118.2 (d, C-6), 105.3 (d, C-5),
2 × 103.3 (d, C-3,-1′), 75.6 (d, C-3′), 73.9 (d, C-5′), 73.3 (d, C-2′),
70.3 (d, C-4′), 64.4 (t, C-6′); FABMS (negative mode) m/z 391
[M - H]-; (positive mode, NBA) m/z 415 [M + Na]+, 392 [M]+.
on RP18 (MeOH-H2O 45:55), giving 2 mg of racemic 3-hy-
droxy,3′-phenyl propanoic acid.
Syn th esis. 4-Hyd r oxyp h en yl-(6′-O-ben zoyl)-O-â-D-glu -
cop yr a n osid e (1). A solution of arbutin (4-hydroxyphenyl-
O-â-D-glucopyranoside; 0.5 g, 1.84 mmol) and benzoic acid (0.27
g, 2.22 mmol) in dry pyridine (30 mL) was distilled with
azeotropic removal of H2O to half volume (15 mL) and then
cooled. BOP-Cl (1.187 g, 4.67 mmol) was added, and the
resulting suspension was stirred at room temperature. The
reaction was monitored by TLC (Si gel, using as eluent the
organic phase of the biphasic system CHCl3-MeOH-H2O 5:5:
3). After 3 h the solvent was removed under reduced pressure,
and the residue was extracted with CHCl3-MeOH-H2O 5:5:3
(30 mL). The organic phase was dried, the solvent was removed
under reduced pressure, and the residue was chromatographed
on Si gel eluting with CHCl3-MeOH 9:1 to afford 4-hydroxy-
phenyl-(6′-O-benzoyl)-O-â-D-glucopyranoside (1) (0.137 g). The
aqueous phase was extracted with EtOAc (3 × 10 mL) and
gave a further 0.390 g of 1. The total amount of crude 1 (0.527
g, 76%) was crystallized from CHCl3-MeOH and afforded
0.420 g of a colorless compound identical in all respect to the
natural compound. As a side product 4-benzoyloxyphenyl-(6′-
O-benzoyl)-O-â-D-glucopyranoside (6) was obtained in 12.5%
yield.
Compound 3 (50 mg) was permethylated under the same
conditions used for 2. After purification, 22 mg of 3a were
Com p ou n d 6: mp 238 °C (CHCl3-MeOH); [R]20 ) -54°
D
1
(c 1, EtOH); Rf 0.58 (CHCl3-MeOH-H2O 5:5:3, organic phase);
1H NMR (DMSO-d6) δ 8.12 (2H, dd, J ) 7.1, 1.5 Hz, H-2′′′+
H-6′′′), 7.97 (2H, dd, J ) 7.0, 1.5 Hz, H-2′′+ H-6′′), 7.80-7.70
(2H, m, H-4′′+ H-4′′′), 7.70-7.50 (4H, m, H-3′′ + H-5′′ +
H-3′′′ + H- 5′′′), 7.10 (4H, m, H-2, -3, -5, -6), 5.52 (2H, s, OH),
5.38 (1H, s, OH), 4.93 (1H, d, J ) 7.1 Hz, H-1′), 4.62 (1H, dd,
J ) 12.0, 1.5 Hz, H-6′), 4.35 (1H, dd, J ) 12.0, 7.0 Hz, H-6),
3.82 (1H, ddd, J ) 7.0, 7.0, 1.5 Hz, H-5′), 3.45 (3H, m, H-2′,
-3′, -4′); 13C NMR (DMSO-d6) δ 165.6 (s), 164.8 (s), 154.9 (s),
145.1 (s), 134.1 (d), 133.4 (d), 130.2 (s), 130.1 (s), 2 × 129.8
(d), 2 × 129.2 (d), 2 × 129.0 (d), 2 × 128.8 (d), 2 × 117.7 (d),
2 × 115.5 (d), 101.5 (d), 73.8 (d), 76.4 (d), 73.3 (d), 70.2 (d),
64.2 (t); FABMS (negative mode) m/z 479 [M - H]-; (positive
mode) m/z 503 [M + Na]+, 481 [M + H]+; anal. C 64.7%, H
5.2%, calcd for C26H24O9, C 64.9%, H 5.1%.
obtained: H NMR (200 MHz, CDCl3); δ 7.07 (1H, d, J ) 8.7
Hz, H-6), 6.50 (1H, d, J ) 2.8 Hz, H-3), 6.38 (1H, dd, J ) 8.7,
2.8 Hz, H-5), 4.66 (1H, d, J ) 7.5 Hz, H-1′), 3.82, 3.70, 3.66,
3.56, 3.41, 3.39 (6 × 3H, s, -OCH3).
Com p ou n d 4: white powder, mp 115-116 °C (EtOH-
CHCl3) [R]20 -61.3° (c 1, MeOH); Rf 0.45 (CHCl3-MeOH-
D
H2O 5:5:3 organic phase); 1H NMR (DMSO-d6, 200 MHz) δ 8.91
and 8.40 (2H, s, phenolic OH), 8.00 (2H, d, J ) 7.0 Hz, H-2′′,-
6′′), 7.60 (2H, t, J ) 7.8 Hz, H-3′′,-5′′), 7.55 (1H, t, J ) 7.5 Hz,
H-4′′), 6.90 (1H, d, J ) 8.7 Hz, H-6), 6.21 (1H, d, J ) 2.7 Hz,
H-3), 5.95 (1H, dd, J ) 8.7, 2.7 Hz, H-5), 5.43 (1H, d, J ) 4.6
Hz, OH), 5.02 (1H, d, J ) 3.5 Hz, OH), 4.98 (1H, d, J ) 7.5
Hz, OH), 4.80 (1H, d, J ) 7.9 Hz, H-1′), 4.60 (1H, dd, J ) 11.8,
1.5 Hz, H-6′A), 4.30 (1H, dd, J ) 11.8, 7.5 Hz, H-6′B), 4.00
(1H, m, H-5′), 3.50 (3H, m, H-2′,-3′,-4′); 13C NMR (DMSO-d6)
δ 166.2 (s, C-7′′), 152.6 (s, C-4), 147.1 (s, C-2), 138.4 (s, C-1),
133.7 (d, C-4′′), 129.3 (s, C-1′′), 2 × 129.2 (d, C-2′′,-6′′), 2 ×
128.9 (d, C-3′′,-5′′), 117.6 (d, C-6), 105.6 (d, C-5), 103.4 (d, C-3),
100.4 (d, C-1′), 71.4 (d, C-5′), 70.8 (d, C-2′), 69.9 (d, C-3′), 67.4
(d, C-4′), 64.6 (t, C-6′); FABMS (negative mode) m/z 391 [M -
H]-, (positive mode) m/z 393 [M + H]+, 267 [M - aromatic
ring]+.
3,4-Meth ylen d ioxyp h en yl-2′,3′,4′,6′- tetr a a cetyl-O-â-D-
glu cop yr a n osid e (7). A solution of tetra-O-acetyl-R-bromo-
D-glucopyranose (2.97 g, 7.2 mmol) and benzyltriethylammo-
nium bromide (810 mg, 2.9 mmol) in CHCl3 (15.8 mL) was
added to a solution of sesamol (3,4-methylenedioxyphenol)
(1.04 g, 7.2 mmol) in NaOH (1.25 M, 8.8 mL). The reaction
was heated in an oil bath at 60 °C. The progress of the reaction
was monitored by TLC (Si gel, eluent n-hexane-ethyl acetate
7:3). After 16 h the reaction mixture was diluted with H2O
(50 mL) and extracted with CHCl3 (3 × 30 mL). The combined
organic phases were dried (Na2SO4) and the solvent removed
under reduced pressure. The crude material (4.46 g) was flash
chromatographed (Si gel, n-hexane-ethyl acetate 7:3) and
afforded 0.31 g of unreacted sesamol (29.8%) and 2.31 g of 7
(68.5%), which was crystallized from n-hexane-ethyl acetate
to afford 1.97 g of colorless crystals.
Compound 4 (30 mg) was permethylated under the same
conditions used for 2. After purification, 18 mg of 6a were
obtained. 2a : 1H NMR (200 MHz, CDCl3); δ 7.05 (1H, d, J )
8.7 Hz, H-6), 6.43 (1H, d, J ) 2.7 Hz, H-3), 6.32 (1H, dd, J )
8.7, 2.7 Hz, H-5), 5.10 (1H, d, J ) 7.5 Hz, H-1′), 3.74, 3.70,
3.62, 3.58, 3.40, 3.34 (6 × 3H, s, -OCH3)
Compound 4a (18 mg) was hydrolyzed under the same
conditions used for 2a , giving 10 mg of 2,4 dimethoxyphenol
1
(4b): H NMR (CDCl3, 200 MHz); δ 6.84 (1H, d, J ) 8.7 Hz,
Com p ou n d 7: mp 162 °C (n-hexane-ethyl acetate); [R]20
D
H-6), 6.50 (1H, d, J ) 2.8 Hz, H-3), 6.40 (1H, dd, J ) 8.7, 2.8
Hz, H5), 5.22 (1H, s, -OH); 3.87 (3H, s, -OCH3), 3.77 (2 ×
3H, s, -OCH3).
-68° (c 1, CHCl3) Rf 0.24 (n-hexane-EtOAc 7:3); 1H NMR
(CDCl3) δ 6.71 (1H, d, J ) 8.3 Hz, H-5), 6.60 (1H, d, J ) 2.3
Hz, H-2), 6.47 (1H, dd, J ) 8.3, 2.3 Hz, H-6), 5.30-5.15 (4H,
m, H-2′ + H-3′ + H-4′), 4.93 (1H, d, J ) 7.6 Hz, H-1′), 4.30
(1H, dd, J ) 12.2, 5.4 Hz, H-6′B), 4.18 (1H, dd, J ) 12.2, 6.0
Hz, H-6′A), 3.82 (1H, m, H-5′), 2.11 (3H, s), 2.09 (3H, s), 2.06
(3H, s), 2.05 (3H, s); 13C NMR (CDCl3) δ 170.4 (s), 170.1 (s),
169.3 (s), 162.2 (s), 151.9 (s), 148.0 (s), 143.5 (s), 109.5 (d), 107.8
(d), 101.3 (t), 100.4 (d), 100.2 (d), 72.6 (d), 71.8 (d), 70.9 (d),
68.1 (d), 61.8 (t), 4 × 20.5 (q); FABMS (negative mode) m/z
467 [M - H]- ; (positive mode) m/z 491 [M + Na]+, 469 [M +
H]+; anal. C 52.9%, H 5.3%, calcd for C21H24O12 C 53.8%, H
5.2%.
Com p ou n d 5: [R]25 -34.2° (c 0.53, MeOH); 1H NMR
D
(DMSO-d6) δ 8.90 (1H, s, OH), 8.42 (1H, s, OH), 7.50-7.30
(5H, m), 6.90 (1H d, J ) 8 Hz, H-6), 6.30 (1H, d, J ) 2 Hz,
H-3), 6.15 (1H, dd, J ) 8, 2 Hz, H-5), 5.00 (1H, t, J ) 7.0 Hz,
H-9′′), 4.45 (1H, d, J ) 7.9 Hz, H-1′), 4.35 (1H, dd, J ) 11.8,
1.5 Hz, H-6′A), 4.05 (1H, dd, J ) 11.8, 7.5 Hz, H-6′B), 2.16
(2H, d, J ) 7.0 Hz, H-8′′); 13C NMR (DMSO-d6) δ 170.5 (s,
C-7′′), 153.7 (s, C-4), 147.9 (s, C-2), 144.7 (s, C-1′′), 138.3 (s,
C-1), 2 × 128.2 (d, C-2′′,-6′′), 2 × 125.8 (d, C3′′,-5′′), 118.7 (d,
C-6), 105.5 (d, C-1′), 2 × 103.0 (d, C-3,5), 75.7 (d, C-3′), 73.9
(d, C-5′), 73.3 (d, C-2′), 70.1 (d, C-4′), 69.4 (d, C-9′′), 63.7 (t,
C-6′), 44.5 (t, C-8′′); FABMS (positive mode) m/z 459 [ M +
Na ]+.
3,4-Dih yd r oxyp h en yl-O-â-D-glu cop yr a n osid e (8). A 0.5
M solution of NaSEt in DMF was prepared by adding EtSH
(0.93 g, 1.1 mL, 15 mmol) to an ice-cooled and magnetically
stirred suspension of NaH (0.4 g of a 60% oil dispersion, 10
mmol) in DMF (10 mL) and stirring at room temperature for
Compound 5 was stirred with Ba(OH)2 (10 mg in 1 mL H2O),
under N2 for 1h. After acidification, the mixture was purified